nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Fluorouracil—head and neck cancer	0.16	0.42	CbGbCtD
Fenofibrate—CYP2C9—Fluorouracil—head and neck cancer	0.112	0.293	CbGbCtD
Fenofibrate—CYP3A4—Vinblastine—head and neck cancer	0.0602	0.158	CbGbCtD
Fenofibrate—CYP3A4—Docetaxel—head and neck cancer	0.0496	0.13	CbGbCtD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.0102	0.064	CbGpPWpGaD
Fenofibrate—Cutaneous hypersensitivity—Docetaxel—head and neck cancer	0.00978	0.0221	CcSEcCtD
Fenofibrate—PPARA—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00911	0.057	CbGpPWpGaD
Fenofibrate—Thromboembolic event—Docetaxel—head and neck cancer	0.00886	0.02	CcSEcCtD
Fenofibrate—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—YAP1—head and neck cancer	0.00852	0.0534	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00825	0.0516	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—RARB—head and neck cancer	0.00755	0.0472	CbGpPWpGaD
Fenofibrate—Peptic ulcer—Vinblastine—head and neck cancer	0.00754	0.017	CcSEcCtD
Fenofibrate—Clofibrate—CYP1A1—head and neck cancer	0.00749	0.484	CrCbGaD
Fenofibrate—Blister—Hydroxyurea—head and neck cancer	0.00637	0.0144	CcSEcCtD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00596	0.0373	CbGpPWpGaD
Fenofibrate—Skin ulcer—Hydroxyurea—head and neck cancer	0.0059	0.0133	CcSEcCtD
Fenofibrate—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00558	0.0126	CcSEcCtD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—CEBPA—head and neck cancer	0.00552	0.0345	CbGpPWpGaD
Fenofibrate—Bezafibrate—CYP1A1—head and neck cancer	0.00547	0.353	CrCbGaD
Fenofibrate—Raised liver function tests—Docetaxel—head and neck cancer	0.00517	0.0117	CcSEcCtD
Fenofibrate—Nail disorder—Fluorouracil—head and neck cancer	0.0051	0.0115	CcSEcCtD
Fenofibrate—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00495	0.0112	CcSEcCtD
Fenofibrate—Duodenal ulcer—Docetaxel—head and neck cancer	0.00494	0.0112	CcSEcCtD
Fenofibrate—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00486	0.011	CcSEcCtD
Fenofibrate—Creatinine increased—Hydroxyurea—head and neck cancer	0.00483	0.0109	CcSEcCtD
Fenofibrate—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00468	0.0106	CcSEcCtD
Fenofibrate—Blister—Fluorouracil—head and neck cancer	0.00459	0.0104	CcSEcCtD
Fenofibrate—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00436	0.0273	CbGpPWpGaD
Fenofibrate—Blood urea increased—Hydroxyurea—head and neck cancer	0.00434	0.00979	CcSEcCtD
Fenofibrate—Phlebitis—Vinblastine—head and neck cancer	0.00424	0.00958	CcSEcCtD
Fenofibrate—PPARA—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00423	0.0265	CbGpPWpGaD
Fenofibrate—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00418	0.00943	CcSEcCtD
Fenofibrate—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00397	0.0248	CbGpPWpGaD
Fenofibrate—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00392	0.00886	CcSEcCtD
Fenofibrate—Embolism—Docetaxel—head and neck cancer	0.00372	0.00839	CcSEcCtD
Fenofibrate—Nail disorder—Docetaxel—head and neck cancer	0.00368	0.00831	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—CEBPA—head and neck cancer	0.00363	0.0227	CbGpPWpGaD
Fenofibrate—Renal failure acute—Hydroxyurea—head and neck cancer	0.00361	0.00816	CcSEcCtD
Fenofibrate—Herpes simplex—Fluorouracil—head and neck cancer	0.00359	0.0081	CcSEcCtD
Fenofibrate—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00355	0.0222	CbGpPWpGaD
Fenofibrate—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00354	0.00798	CcSEcCtD
Fenofibrate—Laryngeal pain—Docetaxel—head and neck cancer	0.0035	0.00791	CcSEcCtD
Fenofibrate—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00349	0.00788	CcSEcCtD
Fenofibrate—Neuralgia—Docetaxel—head and neck cancer	0.00344	0.00776	CcSEcCtD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00328	0.0205	CbGpPWpGaD
Fenofibrate—Dermatitis contact—Fluorouracil—head and neck cancer	0.00327	0.00738	CcSEcCtD
Fenofibrate—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00323	0.0202	CbGpPWpGaD
Fenofibrate—Dermatitis atopic—Docetaxel—head and neck cancer	0.00322	0.00728	CcSEcCtD
Fenofibrate—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00312	0.00705	CcSEcCtD
Fenofibrate—Angina pectoris—Vinblastine—head and neck cancer	0.00308	0.00695	CcSEcCtD
Fenofibrate—Otitis media—Docetaxel—head and neck cancer	0.00307	0.00692	CcSEcCtD
Fenofibrate—Oesophagitis—Fluorouracil—head and neck cancer	0.00302	0.00682	CcSEcCtD
Fenofibrate—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00301	0.00679	CcSEcCtD
Fenofibrate—PPARA—PPARA activates gene expression—YAP1—head and neck cancer	0.00293	0.0184	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—STAT6—head and neck cancer	0.0029	0.0182	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.00287	0.018	CbGpPWpGaD
Fenofibrate—Pancreatitis—Hydroxyurea—head and neck cancer	0.00283	0.00638	CcSEcCtD
Fenofibrate—PPARA—PPAR Alpha Pathway—CCND1—head and neck cancer	0.00281	0.0176	CbGpPWpGaD
Fenofibrate—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00278	0.00627	CcSEcCtD
Fenofibrate—Myocardial infarction—Vinblastine—head and neck cancer	0.00276	0.00624	CcSEcCtD
Fenofibrate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00275	0.0172	CbGpPWpGaD
Fenofibrate—Photosensitivity—Fluorouracil—head and neck cancer	0.00273	0.00617	CcSEcCtD
Fenofibrate—Dysuria—Hydroxyurea—head and neck cancer	0.0027	0.00609	CcSEcCtD
Fenofibrate—Bone disorder—Docetaxel—head and neck cancer	0.00264	0.00597	CcSEcCtD
Fenofibrate—Weight increased—Hydroxyurea—head and neck cancer	0.00262	0.00592	CcSEcCtD
Fenofibrate—Drug interaction—Docetaxel—head and neck cancer	0.00257	0.00581	CcSEcCtD
Fenofibrate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00257	0.0058	CcSEcCtD
Fenofibrate—Infestation—Hydroxyurea—head and neck cancer	0.00257	0.0058	CcSEcCtD
Fenofibrate—Indomethacin—PTGS2—head and neck cancer	0.00253	0.163	CrCbGaD
Fenofibrate—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00252	0.0057	CcSEcCtD
Fenofibrate—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00251	0.00567	CcSEcCtD
Fenofibrate—Pharyngitis—Vinblastine—head and neck cancer	0.00251	0.00567	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00243	0.00549	CcSEcCtD
Fenofibrate—Osteoarthritis—Fluorouracil—head and neck cancer	0.0024	0.00542	CcSEcCtD
Fenofibrate—Pulmonary embolism—Docetaxel—head and neck cancer	0.00239	0.00539	CcSEcCtD
Fenofibrate—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00239	0.00539	CcSEcCtD
Fenofibrate—Colitis—Docetaxel—head and neck cancer	0.00229	0.00517	CcSEcCtD
Fenofibrate—Alopecia—Vinblastine—head and neck cancer	0.00224	0.00505	CcSEcCtD
Fenofibrate—Oesophagitis—Docetaxel—head and neck cancer	0.00218	0.00492	CcSEcCtD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00218	0.0136	CbGpPWpGaD
Fenofibrate—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00215	0.00485	CcSEcCtD
Fenofibrate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00213	0.0133	CbGpPWpGaD
Fenofibrate—Muscular weakness—Fluorouracil—head and neck cancer	0.00212	0.00478	CcSEcCtD
Fenofibrate—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.00209	0.0131	CbGpPWpGaD
Fenofibrate—Angiopathy—Hydroxyurea—head and neck cancer	0.00209	0.00473	CcSEcCtD
Fenofibrate—Eosinophilia—Fluorouracil—head and neck cancer	0.00205	0.00464	CcSEcCtD
Fenofibrate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00204	0.00461	CcSEcCtD
Fenofibrate—Alopecia—Hydroxyurea—head and neck cancer	0.00204	0.0046	CcSEcCtD
Fenofibrate—Anaemia—Vinblastine—head and neck cancer	0.00204	0.0046	CcSEcCtD
Fenofibrate—Angina pectoris—Fluorouracil—head and neck cancer	0.00202	0.00456	CcSEcCtD
Fenofibrate—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00201	0.0126	CbGpPWpGaD
Fenofibrate—Phlebitis—Docetaxel—head and neck cancer	0.00201	0.00454	CcSEcCtD
Fenofibrate—Erythema—Hydroxyurea—head and neck cancer	0.00201	0.00453	CcSEcCtD
Fenofibrate—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00199	0.0045	CcSEcCtD
Fenofibrate—Malaise—Vinblastine—head and neck cancer	0.00199	0.00448	CcSEcCtD
Fenofibrate—Vertigo—Vinblastine—head and neck cancer	0.00198	0.00447	CcSEcCtD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00198	0.0124	CbGpPWpGaD
Fenofibrate—Leukopenia—Vinblastine—head and neck cancer	0.00197	0.00445	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00193	0.00435	CcSEcCtD
Fenofibrate—Hypertension—Vinblastine—head and neck cancer	0.0019	0.00429	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00189	0.00428	CcSEcCtD
Fenofibrate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00186	0.00421	CcSEcCtD
Fenofibrate—Pneumonia—Fluorouracil—head and neck cancer	0.00186	0.0042	CcSEcCtD
Fenofibrate—Anaemia—Hydroxyurea—head and neck cancer	0.00186	0.00419	CcSEcCtD
Fenofibrate—Discomfort—Vinblastine—head and neck cancer	0.00185	0.00418	CcSEcCtD
Fenofibrate—Infestation NOS—Fluorouracil—head and neck cancer	0.00185	0.00418	CcSEcCtD
Fenofibrate—Infestation—Fluorouracil—head and neck cancer	0.00185	0.00418	CcSEcCtD
Fenofibrate—Atrial fibrillation—Docetaxel—head and neck cancer	0.00183	0.00413	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00182	0.00412	CcSEcCtD
Fenofibrate—Renal impairment—Docetaxel—head and neck cancer	0.00182	0.00411	CcSEcCtD
Fenofibrate—Myocardial infarction—Fluorouracil—head and neck cancer	0.00181	0.00409	CcSEcCtD
Fenofibrate—Dermatitis bullous—Docetaxel—head and neck cancer	0.00181	0.00409	CcSEcCtD
Fenofibrate—Malaise—Hydroxyurea—head and neck cancer	0.00181	0.00409	CcSEcCtD
Fenofibrate—Urinary tract infection—Fluorouracil—head and neck cancer	0.0018	0.00406	CcSEcCtD
Fenofibrate—Conjunctivitis—Fluorouracil—head and neck cancer	0.0018	0.00406	CcSEcCtD
Fenofibrate—Leukopenia—Hydroxyurea—head and neck cancer	0.0018	0.00406	CcSEcCtD
Fenofibrate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00176	0.00397	CcSEcCtD
Fenofibrate—Sinusitis—Fluorouracil—head and neck cancer	0.00174	0.00392	CcSEcCtD
Fenofibrate—Pain in extremity—Docetaxel—head and neck cancer	0.00173	0.00391	CcSEcCtD
Fenofibrate—Anorexia—Vinblastine—head and neck cancer	0.00171	0.00387	CcSEcCtD
Fenofibrate—Migraine—Docetaxel—head and neck cancer	0.00171	0.00385	CcSEcCtD
Fenofibrate—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.0017	0.0107	CbGpPWpGaD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0017	0.00383	CcSEcCtD
Fenofibrate—Discomfort—Hydroxyurea—head and neck cancer	0.00169	0.00381	CcSEcCtD
Fenofibrate—Rhinitis—Fluorouracil—head and neck cancer	0.00166	0.00376	CcSEcCtD
Fenofibrate—PPARA—PPARA activates gene expression—CYP1A1—head and neck cancer	0.00165	0.0103	CbGpPWpGaD
Fenofibrate—Pharyngitis—Fluorouracil—head and neck cancer	0.00165	0.00372	CcSEcCtD
Fenofibrate—Oedema—Hydroxyurea—head and neck cancer	0.00164	0.0037	CcSEcCtD
Fenofibrate—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00164	0.0103	CbGpPWpGaD
Fenofibrate—Infection—Hydroxyurea—head and neck cancer	0.00163	0.00368	CcSEcCtD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.00162	0.0101	CbGpPWpGaD
Fenofibrate—Paraesthesia—Vinblastine—head and neck cancer	0.00161	0.00364	CcSEcCtD
Fenofibrate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00161	0.00363	CcSEcCtD
Fenofibrate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0016	0.00362	CcSEcCtD
Fenofibrate—Liver function test abnormal—Docetaxel—head and neck cancer	0.0016	0.00361	CcSEcCtD
Fenofibrate—Skin disorder—Hydroxyurea—head and neck cancer	0.00159	0.00359	CcSEcCtD
Fenofibrate—Anorexia—Hydroxyurea—head and neck cancer	0.00156	0.00353	CcSEcCtD
Fenofibrate—Decreased appetite—Vinblastine—head and neck cancer	0.00156	0.00353	CcSEcCtD
Fenofibrate—Cramp muscle—Docetaxel—head and neck cancer	0.00156	0.00352	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00156	0.00352	CcSEcCtD
Fenofibrate—Nasopharyngitis—Docetaxel—head and neck cancer	0.00155	0.0035	CcSEcCtD
Fenofibrate—Constipation—Vinblastine—head and neck cancer	0.00154	0.00347	CcSEcCtD
Fenofibrate—Pain—Vinblastine—head and neck cancer	0.00154	0.00347	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00153	0.00345	CcSEcCtD
Fenofibrate—Arrhythmia—Fluorouracil—head and neck cancer	0.00148	0.00335	CcSEcCtD
Fenofibrate—Feeling abnormal—Vinblastine—head and neck cancer	0.00148	0.00334	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00147	0.00332	CcSEcCtD
Fenofibrate—Alopecia—Fluorouracil—head and neck cancer	0.00147	0.00331	CcSEcCtD
Fenofibrate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00146	0.0033	CcSEcCtD
Fenofibrate—Angina pectoris—Docetaxel—head and neck cancer	0.00146	0.00329	CcSEcCtD
Fenofibrate—Somnolence—Hydroxyurea—head and neck cancer	0.00146	0.00329	CcSEcCtD
Fenofibrate—Erythema—Fluorouracil—head and neck cancer	0.00145	0.00326	CcSEcCtD
Fenofibrate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00144	0.00326	CcSEcCtD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00144	0.00899	CbGpPWpGaD
Fenofibrate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00142	0.00322	CcSEcCtD
Fenofibrate—Abdominal pain—Vinblastine—head and neck cancer	0.00142	0.00321	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00142	0.0032	CcSEcCtD
Fenofibrate—Fatigue—Hydroxyurea—head and neck cancer	0.00141	0.00319	CcSEcCtD
Fenofibrate—Pain—Hydroxyurea—head and neck cancer	0.0014	0.00316	CcSEcCtD
Fenofibrate—Constipation—Hydroxyurea—head and neck cancer	0.0014	0.00316	CcSEcCtD
Fenofibrate—Weight increased—Docetaxel—head and neck cancer	0.00136	0.00308	CcSEcCtD
Fenofibrate—Weight decreased—Docetaxel—head and neck cancer	0.00135	0.00306	CcSEcCtD
Fenofibrate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00135	0.00305	CcSEcCtD
Fenofibrate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00134	0.00841	CbGpPWpGaD
Fenofibrate—Pneumonia—Docetaxel—head and neck cancer	0.00134	0.00303	CcSEcCtD
Fenofibrate—Anaemia—Fluorouracil—head and neck cancer	0.00134	0.00302	CcSEcCtD
Fenofibrate—Infestation NOS—Docetaxel—head and neck cancer	0.00134	0.00301	CcSEcCtD
Fenofibrate—Infestation—Docetaxel—head and neck cancer	0.00134	0.00301	CcSEcCtD
Fenofibrate—Hypersensitivity—Vinblastine—head and neck cancer	0.00132	0.00299	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00132	0.00297	CcSEcCtD
Fenofibrate—Renal failure—Docetaxel—head and neck cancer	0.00131	0.00296	CcSEcCtD
Fenofibrate—Myocardial infarction—Docetaxel—head and neck cancer	0.00131	0.00295	CcSEcCtD
Fenofibrate—Jaundice—Docetaxel—head and neck cancer	0.0013	0.00294	CcSEcCtD
Fenofibrate—Conjunctivitis—Docetaxel—head and neck cancer	0.0013	0.00293	CcSEcCtD
Fenofibrate—Body temperature increased—Hydroxyurea—head and neck cancer	0.0013	0.00293	CcSEcCtD
Fenofibrate—Leukopenia—Fluorouracil—head and neck cancer	0.00129	0.00292	CcSEcCtD
Fenofibrate—Asthenia—Vinblastine—head and neck cancer	0.00129	0.00291	CcSEcCtD
Fenofibrate—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00129	0.00807	CbGpPWpGaD
Fenofibrate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00126	0.00285	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—CEBPA—head and neck cancer	0.00125	0.0078	CbGpPWpGaD
Fenofibrate—Myalgia—Fluorouracil—head and neck cancer	0.00123	0.00278	CcSEcCtD
Fenofibrate—Chest pain—Fluorouracil—head and neck cancer	0.00123	0.00278	CcSEcCtD
Fenofibrate—Diarrhoea—Vinblastine—head and neck cancer	0.00123	0.00278	CcSEcCtD
Fenofibrate—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00122	0.00765	CbGpPWpGaD
Fenofibrate—Discomfort—Fluorouracil—head and neck cancer	0.00122	0.00275	CcSEcCtD
Fenofibrate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00121	0.00273	CcSEcCtD
Fenofibrate—Rhinitis—Docetaxel—head and neck cancer	0.0012	0.00271	CcSEcCtD
Fenofibrate—Hepatitis—Docetaxel—head and neck cancer	0.0012	0.00271	CcSEcCtD
Fenofibrate—Pharyngitis—Docetaxel—head and neck cancer	0.00119	0.00269	CcSEcCtD
Fenofibrate—Dizziness—Vinblastine—head and neck cancer	0.00119	0.00268	CcSEcCtD
Fenofibrate—Oedema peripheral—Docetaxel—head and neck cancer	0.00118	0.00267	CcSEcCtD
Fenofibrate—Oedema—Fluorouracil—head and neck cancer	0.00118	0.00266	CcSEcCtD
Fenofibrate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00118	0.00266	CcSEcCtD
Fenofibrate—Asthenia—Hydroxyurea—head and neck cancer	0.00118	0.00266	CcSEcCtD
Fenofibrate—Infection—Fluorouracil—head and neck cancer	0.00117	0.00265	CcSEcCtD
Fenofibrate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00116	0.00261	CcSEcCtD
Fenofibrate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00116	0.00261	CcSEcCtD
Fenofibrate—Visual impairment—Docetaxel—head and neck cancer	0.00116	0.00261	CcSEcCtD
Fenofibrate—Tachycardia—Fluorouracil—head and neck cancer	0.00115	0.0026	CcSEcCtD
Fenofibrate—Vomiting—Vinblastine—head and neck cancer	0.00114	0.00258	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00114	0.00713	CbGpPWpGaD
Fenofibrate—Headache—Vinblastine—head and neck cancer	0.00113	0.00254	CcSEcCtD
Fenofibrate—Anorexia—Fluorouracil—head and neck cancer	0.00112	0.00254	CcSEcCtD
Fenofibrate—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00112	0.00703	CbGpPWpGaD
Fenofibrate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00112	0.00253	CcSEcCtD
Fenofibrate—Eye disorder—Docetaxel—head and neck cancer	0.00112	0.00253	CcSEcCtD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.00111	0.00697	CbGpPWpGaD
Fenofibrate—Cardiac disorder—Docetaxel—head and neck cancer	0.00111	0.00251	CcSEcCtD
Fenofibrate—Hypotension—Fluorouracil—head and neck cancer	0.0011	0.00249	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—TYMS—head and neck cancer	0.00109	0.00681	CbGpPWpGaD
Fenofibrate—Angiopathy—Docetaxel—head and neck cancer	0.00109	0.00246	CcSEcCtD
Fenofibrate—Dizziness—Hydroxyurea—head and neck cancer	0.00108	0.00245	CcSEcCtD
Fenofibrate—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00108	0.00676	CbGpPWpGaD
Fenofibrate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00108	0.00244	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00107	0.00243	CcSEcCtD
Fenofibrate—Arrhythmia—Docetaxel—head and neck cancer	0.00107	0.00242	CcSEcCtD
Fenofibrate—Nausea—Vinblastine—head and neck cancer	0.00107	0.00241	CcSEcCtD
Fenofibrate—Insomnia—Fluorouracil—head and neck cancer	0.00107	0.00241	CcSEcCtD
Fenofibrate—Paraesthesia—Fluorouracil—head and neck cancer	0.00106	0.00239	CcSEcCtD
Fenofibrate—Alopecia—Docetaxel—head and neck cancer	0.00106	0.00239	CcSEcCtD
Fenofibrate—Dyspnoea—Fluorouracil—head and neck cancer	0.00105	0.00237	CcSEcCtD
Fenofibrate—Mental disorder—Docetaxel—head and neck cancer	0.00105	0.00237	CcSEcCtD
Fenofibrate—Somnolence—Fluorouracil—head and neck cancer	0.00105	0.00237	CcSEcCtD
Fenofibrate—Malnutrition—Docetaxel—head and neck cancer	0.00104	0.00236	CcSEcCtD
Fenofibrate—Erythema—Docetaxel—head and neck cancer	0.00104	0.00236	CcSEcCtD
Fenofibrate—Vomiting—Hydroxyurea—head and neck cancer	0.00104	0.00235	CcSEcCtD
Fenofibrate—Dyspepsia—Fluorouracil—head and neck cancer	0.00104	0.00234	CcSEcCtD
Fenofibrate—Rash—Hydroxyurea—head and neck cancer	0.00103	0.00233	CcSEcCtD
Fenofibrate—Dermatitis—Hydroxyurea—head and neck cancer	0.00103	0.00233	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—RARB—head and neck cancer	0.00103	0.00645	CbGpPWpGaD
Fenofibrate—Headache—Hydroxyurea—head and neck cancer	0.00103	0.00232	CcSEcCtD
Fenofibrate—Decreased appetite—Fluorouracil—head and neck cancer	0.00103	0.00232	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00102	0.0023	CcSEcCtD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00102	0.00636	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—UROD—head and neck cancer	0.00102	0.00636	CbGpPWpGaD
Fenofibrate—Back pain—Docetaxel—head and neck cancer	0.00101	0.00228	CcSEcCtD
Fenofibrate—Pain—Fluorouracil—head and neck cancer	0.00101	0.00228	CcSEcCtD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00101	0.0063	CbGpPWpGaD
Fenofibrate—Muscle spasms—Docetaxel—head and neck cancer	0.001	0.00226	CcSEcCtD
Fenofibrate—Nausea—Hydroxyurea—head and neck cancer	0.000974	0.0022	CcSEcCtD
Fenofibrate—Feeling abnormal—Fluorouracil—head and neck cancer	0.000972	0.0022	CcSEcCtD
Fenofibrate—Anaemia—Docetaxel—head and neck cancer	0.000964	0.00218	CcSEcCtD
Fenofibrate—Urticaria—Fluorouracil—head and neck cancer	0.000937	0.00212	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—YAP1—head and neck cancer	0.000937	0.00587	CbGpPWpGaD
Fenofibrate—Leukopenia—Docetaxel—head and neck cancer	0.000934	0.00211	CcSEcCtD
Fenofibrate—Body temperature increased—Fluorouracil—head and neck cancer	0.000933	0.00211	CcSEcCtD
Fenofibrate—Palpitations—Docetaxel—head and neck cancer	0.000922	0.00208	CcSEcCtD
Fenofibrate—Cough—Docetaxel—head and neck cancer	0.00091	0.00206	CcSEcCtD
Fenofibrate—Hypertension—Docetaxel—head and neck cancer	0.000901	0.00203	CcSEcCtD
Fenofibrate—Chest pain—Docetaxel—head and neck cancer	0.000888	0.00201	CcSEcCtD
Fenofibrate—Arthralgia—Docetaxel—head and neck cancer	0.000888	0.00201	CcSEcCtD
Fenofibrate—Myalgia—Docetaxel—head and neck cancer	0.000888	0.00201	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000882	0.00199	CcSEcCtD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000869	0.00544	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000869	0.00196	CcSEcCtD
Fenofibrate—Dry mouth—Docetaxel—head and neck cancer	0.000869	0.00196	CcSEcCtD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000858	0.00537	CbGpPWpGaD
Fenofibrate—Oedema—Docetaxel—head and neck cancer	0.000852	0.00192	CcSEcCtD
Fenofibrate—Infection—Docetaxel—head and neck cancer	0.000846	0.00191	CcSEcCtD
Fenofibrate—Nervous system disorder—Docetaxel—head and neck cancer	0.000835	0.00189	CcSEcCtD
Fenofibrate—Pruritus—Fluorouracil—head and neck cancer	0.000835	0.00188	CcSEcCtD
Fenofibrate—Thrombocytopenia—Docetaxel—head and neck cancer	0.000834	0.00188	CcSEcCtD
Fenofibrate—Tachycardia—Docetaxel—head and neck cancer	0.000831	0.00188	CcSEcCtD
Fenofibrate—Skin disorder—Docetaxel—head and neck cancer	0.000827	0.00187	CcSEcCtD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000827	0.00518	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000819	0.00512	CbGpPWpGaD
Fenofibrate—Anorexia—Docetaxel—head and neck cancer	0.000812	0.00183	CcSEcCtD
Fenofibrate—Diarrhoea—Fluorouracil—head and neck cancer	0.000807	0.00182	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000799	0.005	CbGpPWpGaD
Fenofibrate—Hypotension—Docetaxel—head and neck cancer	0.000796	0.0018	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000788	0.00494	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000788	0.00493	CbGpPWpGaD
Fenofibrate—Dizziness—Fluorouracil—head and neck cancer	0.00078	0.00176	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000776	0.00175	CcSEcCtD
Fenofibrate—Insomnia—Docetaxel—head and neck cancer	0.00077	0.00174	CcSEcCtD
Fenofibrate—Paraesthesia—Docetaxel—head and neck cancer	0.000765	0.00173	CcSEcCtD
Fenofibrate—Dyspnoea—Docetaxel—head and neck cancer	0.000759	0.00171	CcSEcCtD
Fenofibrate—Somnolence—Docetaxel—head and neck cancer	0.000757	0.00171	CcSEcCtD
Fenofibrate—Vomiting—Fluorouracil—head and neck cancer	0.00075	0.00169	CcSEcCtD
Fenofibrate—Dyspepsia—Docetaxel—head and neck cancer	0.00075	0.00169	CcSEcCtD
Fenofibrate—Rash—Fluorouracil—head and neck cancer	0.000744	0.00168	CcSEcCtD
Fenofibrate—Dermatitis—Fluorouracil—head and neck cancer	0.000743	0.00168	CcSEcCtD
Fenofibrate—Decreased appetite—Docetaxel—head and neck cancer	0.00074	0.00167	CcSEcCtD
Fenofibrate—Headache—Fluorouracil—head and neck cancer	0.000739	0.00167	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000735	0.00166	CcSEcCtD
Fenofibrate—Fatigue—Docetaxel—head and neck cancer	0.000734	0.00166	CcSEcCtD
Fenofibrate—Pain—Docetaxel—head and neck cancer	0.000728	0.00164	CcSEcCtD
Fenofibrate—Constipation—Docetaxel—head and neck cancer	0.000728	0.00164	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000707	0.00443	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000705	0.00441	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Docetaxel—head and neck cancer	0.000702	0.00158	CcSEcCtD
Fenofibrate—Nausea—Fluorouracil—head and neck cancer	0.000701	0.00158	CcSEcCtD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000698	0.00437	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000696	0.00157	CcSEcCtD
Fenofibrate—Body temperature increased—Docetaxel—head and neck cancer	0.000673	0.00152	CcSEcCtD
Fenofibrate—Abdominal pain—Docetaxel—head and neck cancer	0.000673	0.00152	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—STAT3—head and neck cancer	0.00067	0.00419	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000651	0.00407	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000642	0.00402	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Docetaxel—head and neck cancer	0.000627	0.00142	CcSEcCtD
Fenofibrate—Asthenia—Docetaxel—head and neck cancer	0.000611	0.00138	CcSEcCtD
Fenofibrate—Pruritus—Docetaxel—head and neck cancer	0.000602	0.00136	CcSEcCtD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000598	0.00374	CbGpPWpGaD
Fenofibrate—Diarrhoea—Docetaxel—head and neck cancer	0.000583	0.00132	CcSEcCtD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000577	0.00361	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000573	0.00359	CbGpPWpGaD
Fenofibrate—Dizziness—Docetaxel—head and neck cancer	0.000563	0.00127	CcSEcCtD
Fenofibrate—Vomiting—Docetaxel—head and neck cancer	0.000541	0.00122	CcSEcCtD
Fenofibrate—Rash—Docetaxel—head and neck cancer	0.000537	0.00121	CcSEcCtD
Fenofibrate—Dermatitis—Docetaxel—head and neck cancer	0.000536	0.00121	CcSEcCtD
Fenofibrate—Headache—Docetaxel—head and neck cancer	0.000533	0.0012	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—PTEN—head and neck cancer	0.000528	0.00331	CbGpPWpGaD
Fenofibrate—Nausea—Docetaxel—head and neck cancer	0.000506	0.00114	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—RARB—head and neck cancer	0.000496	0.0031	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000487	0.00305	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000467	0.00292	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00046	0.00288	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—YAP1—head and neck cancer	0.000451	0.00282	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000448	0.0028	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000443	0.00277	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000429	0.00269	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000423	0.00265	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000422	0.00264	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NAT2—head and neck cancer	0.000422	0.00264	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—NOTCH1—head and neck cancer	0.000398	0.00249	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000395	0.00247	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000389	0.00244	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000378	0.00237	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000374	0.00234	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—DPYD—head and neck cancer	0.00037	0.00231	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000369	0.00231	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—head and neck cancer	0.000361	0.00226	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—YAP1—head and neck cancer	0.000351	0.0022	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—UROD—head and neck cancer	0.000329	0.00206	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000321	0.00201	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000317	0.00198	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000305	0.00191	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.0003	0.00188	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—UROD—head and neck cancer	0.000268	0.00168	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000264	0.00165	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000255	0.0016	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—VEGFA—head and neck cancer	0.000232	0.00146	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—STAT3—head and neck cancer	0.00023	0.00144	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00023	0.00144	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MAPK3—head and neck cancer	0.00022	0.00138	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000212	0.00133	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—TYMS—head and neck cancer	0.000211	0.00132	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MAPK1—head and neck cancer	0.000209	0.00131	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EGFR—head and neck cancer	0.000209	0.00131	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000209	0.00131	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTM1—head and neck cancer	0.000208	0.0013	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000208	0.0013	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NOTCH1—head and neck cancer	0.000203	0.00127	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000201	0.00126	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GPX1—head and neck cancer	0.000199	0.00125	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000198	0.00124	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP1A1—head and neck cancer	0.000197	0.00124	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—UROD—head and neck cancer	0.000177	0.00111	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—HRAS—head and neck cancer	0.000168	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000162	0.00102	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—AKT1—head and neck cancer	0.000148	0.000929	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000145	0.000909	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000144	0.0009	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NAT2—head and neck cancer	0.000137	0.000856	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—DPYD—head and neck cancer	0.00012	0.000751	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000118	0.00074	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS2—head and neck cancer	0.000117	0.000735	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000117	0.000732	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—YAP1—head and neck cancer	0.000114	0.000712	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MAPK3—head and neck cancer	0.000112	0.000704	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NAT2—head and neck cancer	0.000111	0.000697	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTEN—head and neck cancer	0.000102	0.000641	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—DPYD—head and neck cancer	9.76e-05	0.000611	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—YAP1—head and neck cancer	9.26e-05	0.00058	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.55e-05	0.000535	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—AKT1—head and neck cancer	7.59e-05	0.000475	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.45e-05	0.000467	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NAT2—head and neck cancer	7.34e-05	0.000459	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—head and neck cancer	7.22e-05	0.000452	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.96e-05	0.000436	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TYMS—head and neck cancer	6.83e-05	0.000428	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTM1—head and neck cancer	6.75e-05	0.000423	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GPX1—head and neck cancer	6.47e-05	0.000405	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—DPYD—head and neck cancer	6.43e-05	0.000403	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1A1—head and neck cancer	6.4e-05	0.000401	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—YAP1—head and neck cancer	6.11e-05	0.000382	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.07e-05	0.00038	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKT1—head and neck cancer	5.9e-05	0.000369	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TYMS—head and neck cancer	5.56e-05	0.000348	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTM1—head and neck cancer	5.5e-05	0.000344	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GPX1—head and neck cancer	5.26e-05	0.000329	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.26e-05	0.000329	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.21e-05	0.000326	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.28e-05	0.000268	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.81e-05	0.000238	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TYMS—head and neck cancer	3.67e-05	0.00023	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.62e-05	0.000227	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GPX1—head and neck cancer	3.47e-05	0.000217	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.44e-05	0.000215	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTEN—head and neck cancer	3.32e-05	0.000208	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.1e-05	0.000194	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTEN—head and neck cancer	2.7e-05	0.000169	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.34e-05	0.000147	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.04e-05	0.000128	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKT1—head and neck cancer	1.91e-05	0.00012	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.91e-05	0.000119	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000112	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKT1—head and neck cancer	1.56e-05	9.75e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.26e-05	7.87e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKT1—head and neck cancer	1.03e-05	6.43e-05	CbGpPWpGaD
